These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 23374705

  • 1. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
    Du C, Deng D, Shan L, Wan S, Cao J, Tian J, Achilefu S, Gu Y.
    Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.
    Qu X, Yang C, Zhang J, Ding N, Lu Y, Huang L, Xiang G.
    J Drug Target; 2010 Jun; 18(5):351-61. PubMed ID: 20001219
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
    Chen C, Hu H, Qiao M, Zhao X, Wang Y, Chen K, Guo X, Chen D.
    Int J Pharm; 2015 Mar 01; 480(1-2):116-27. PubMed ID: 25615984
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.
    Huang S, Fang R, Xu J, Qiu S, Zhang H, Du J, Cai S.
    J Drug Target; 2011 Aug 01; 19(7):487-96. PubMed ID: 21284542
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug.
    Shanmugam V, Chien YH, Cheng YS, Liu TY, Huang CC, Su CH, Chen YS, Kumar U, Hsu HF, Yeh CS.
    ACS Appl Mater Interfaces; 2014 Mar 26; 6(6):4382-93. PubMed ID: 24559392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW, Xiang B, Gao W, Yang ZZ, Li JQ, Qi XR.
    Biomaterials; 2013 Jul 26; 34(20):4849-59. PubMed ID: 23541420
    [Abstract] [Full Text] [Related]

  • 16. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z, Li Y, Kohama K, Oneill B, Bi J.
    Pharmacol Res; 2011 Jan 26; 63(1):51-8. PubMed ID: 21035550
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X, Liao W, Xie Z, Chen D, Zhang CY.
    Mater Sci Eng C Mater Biol Appl; 2018 Sep 01; 90():27-37. PubMed ID: 29853091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.